EXINI Diagnostics provides advanced software for image analysis, increasing accuracy and improving clinical time- flow when treating e.g. advanced prostate cancer.
BSI is a useful tool in clinical trials of new drugs and by physicians to follow treatment effects
on their patients.
EXINI has developed a fully automated method do calculate BSI from bone scintigraphy scans using our software EXINI bone.
Listed at NASDAQ OMX First North (EXINI – ISIN SE0001810284)
